Evidence map›Paper›PMID 39906120›Full record

ArticlePulmonary circulation2025

Treatment pathways in Finnish patients with pulmonary arterial hypertension (PAH) or chronic thromboembolic pulmonary hypertension (CTEPH).

Markku Pentikäinen, Piia Simonen, Pauliina Leskelä, Terttu Harju, Pertti Jääskeläinen, Christian Asseburg, Minna Oksanen, Erkki Soini, Christina Wennerström, Airi Puhakka and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pulmonary circulation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Markku PentikäinenHelsinki University Hospital University of Helsinki Helsinki Finland.ORCID 0009-0008-5393-6255
Piia SimonenHelsinki University Hospital University of Helsinki Helsinki Finland.
Pauliina LeskeläTampere University Hospital Tampere Finland.
Terttu HarjuOulu University Hospital Oulu Finland.ORCID 0000-0003-4564-315X
Pertti JääskeläinenKuopio University Hospital Kuopio Finland.
Christian AsseburgESiOR Oy Kuopio Finland.ORCID 0000-0001-7196-3363
Minna OksanenESiOR Oy Kuopio Finland.
Erkki SoiniESiOR Oy Kuopio Finland.ORCID 0000-0003-4259-7610
Christina WennerströmJanssen-Cilag AB Solna Sweden.ORCID 0000-0002-0111-3416
Airi PuhakkaJanssen-Cilag Oy Espoo Finland.
FINPAH study group
Katriina KahlosOulu University Hospital Oulu Finland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Treatment patterns of pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) in Finland are unknown. Guidelines now recommend early escalation of treatment for PAH. We evaluated how well Finnish practice follows guidelines, and how treatment initiations and outcomes are related. The pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension patients in Finland cohort includes all PAH and CTEPH patients diagnosed between 2008 and 2020 in all Finnish university hospitals. Drug therapy was analysed in patients with medical/procedural history available, and changes in the 4-tier comparative, prospective registry of newly initiated therapies for pulmonary hypertension (COMPERA) 2.0 risk score were evaluated. PAH patients (

Indexed as

chronic thromboembolic pulmonary hypertensionpulmonary arterial hypertensionreal‐world evidencetreatment

Identifiers

PMID39906120
PMCPMC11791409

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.